Literature DB >> 26113757

Diffuse reflectance spectra measured in vivo in human tissues during Photofrin-mediated pleural photodynamic therapy.

Jarod C Finlay1, Timothy C Zhu1, Andreea Dimofte1, Joseph S Friedberg2, Stephen M Hahn1.   

Abstract

Optimal delivery of light in photodynamic therapy (PDT) requires not only optimal placement and power of light sources, but knowledge of the dynamics of light propagation in the tissue being treated and in the surrounding normal tissue, and of their respective accumulations of sensitizer. In an effort to quantify both tissue optical properties and sensitizer distribution, we have measured fluorescence emission and diffuse reflectance spectra at the surface of a variety of tissue types in the thoracic cavities of human patients. The patients studied here were enrolled in Phase II clinical trials of Photofrin-mediated PDT for the treatment of non-small cell lung cancer and cancers with pleural effusion. Patients were given Photofrin at dose of 2 mg per kg body weight 24 hours prior to treatment. Each patient received surgical resection of the affected lung and pleura. Patients received intracavity PDT at 630nm to a dose of 30 J/cm2, as determined by isotropic detectors sutured to the cavity walls. We measured the diffuse reflectance spectra before and after PDT in various positions within the cavity, including tumor, diaphragm, pericardium, skin, and chest wall muscle in 5 patients. The measurements we acquired using a specially designed fiber optic-based probe consisting of one fluorescence excitation fiber, one white light delivery fiber, and 9 detection fibers spaced at distances from 0.36 to 7.8 mm from the source, all of which are imaged via a spectrograph onto a CCD, allowing measurement of radially-resolved diffuse reflectance and fluorescence spectra. The light sources for these two measurements (a 403-nm diode laser and a halogen lamp, respectively) were blocked by computer-controlled shutters, allowing sequential fluorescence, reflectance, and background acquisition. The diffuse reflectance was analyzed to determine the absorption and scattering spectra of the tissue and from these, the concentration and oxygenation of hemoglobin and the local drug uptake. The total hemoglobin concentration in normal tissues varied from 50 to 300 μM, and the oxygen saturation was generally above 60%. One tumor measured exhibited higher hemoglobin concentration and lower saturation.

Entities:  

Keywords:  Photofrin; diffuse reflectance; fluorescence spectroscopy; photodynamic therapy

Year:  2006        PMID: 26113757      PMCID: PMC4477710          DOI: 10.1117/12.647016

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  9 in total

1.  Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation.

Authors:  Jarod C Finlay; Thomas H Foster
Journal:  Med Phys       Date:  2004-07       Impact factor: 4.071

2.  Intraoperative photodynamic therapy for malignant mesothelioma.

Authors:  H I Pass; Z Tochner; T DeLaney; P Smith; W Friauf; E Glatstein; W Travis
Journal:  Ann Thorac Surg       Date:  1990-10       Impact factor: 4.330

3.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

Authors:  B C Wilson; M S Patterson; L Lilge
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

4.  A method for determination of the absorption and scattering properties interstitially in turbid media.

Authors:  Andreea Dimofte; Jarod C Finlay; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2005-05-05       Impact factor: 3.609

5.  Design and testing of a white-light, steady-state diffuse reflectance spectrometer for determination of optical properties of highly scattering systems.

Authors:  M G Nichols; E L Hull; T H Foster
Journal:  Appl Opt       Date:  1997-01-01       Impact factor: 1.980

6.  In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy.

Authors:  Jarod C Finlay; Timothy C Zhu; Andreea Dimofte; Diana Stripp; S Bruce Malkowicz; Richard Whittington; Jeremy Miles; Eli Glatstein; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-06-14

7.  Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy.

Authors:  Hsing-Wen Wang; Timothy C Zhu; Mary E Putt; Michael Solonenko; James Metz; Andreea Dimofte; Jeremy Miles; Douglas L Fraker; Eli Glatstein; Stephen M Hahn; Arjun G Yodh
Journal:  J Biomed Opt       Date:  2005 Jan-Feb       Impact factor: 3.170

8.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

9.  Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread.

Authors:  Joseph S Friedberg; Rosemarie Mick; James P Stevenson; Timothy Zhu; Theresa M Busch; Daniel Shin; Debbie Smith; Melissa Culligan; Andreea Dimofte; Eli Glatstein; Stephen M Hahn
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

  9 in total
  11 in total

1.  In-vivo light dosimetry for HPPH-mediated pleural PDT.

Authors:  Andreea Dimofte; Timothy C Zhu; Jarod C Finlay; Melissa Cullighan; Christine E Edmonds; Joseph S Friedberg; Keith Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-03-04

2.  Light dosimetry and dose verification for pleural PDT.

Authors:  Andreea Dimofte; Anna V Sharikova; Julia L Meo; Charles B Simone; Joseph S Friedberg; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-02-02

3.  Reactive Oxygen Species Explicit Dosimetry for Photofrin-mediated Pleural Photodynamic Therapy.

Authors:  Yi Hong Ong; Andreaa Dimofte; Michele M Kim; Jarod C Finlay; Tianqi Sheng; Sunil Singhal; Keith A Cengel; Arjun G Yodh; Theresa M Busch; Timothy C Zhu
Journal:  Photochem Photobiol       Date:  2019-12-06       Impact factor: 3.421

4.  Determination of optical properties, drug concentration, and tissue oxygenation in human pleural tissue before and after Photofrin-mediated photodynamic therapy.

Authors:  Yi Hong Ong; Jonah Padawer-Curry; Jarod C Finlay; Michele M Kim; Andreea Dimofte; Keith Cengel; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-03

5.  Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.

Authors:  Haixia Qiu; Michele M Kim; Rozhin Penjweini; Timothy C Zhu
Journal:  J Biomed Opt       Date:  2016-08-01       Impact factor: 3.170

6.  Spectroscopic evaluation of photodynamic therapy of the intraperitoneal cavity.

Authors:  Jarod C Finlay; Julia L Sandell; Timothy C Zhu; Robert Lewis; Keith A Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01-23

7.  The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype.

Authors:  Sivaveera Kandasamy; Gautam Adhikary; Ellen A Rorke; Joseph S Friedberg; McKayla B Mickle; H Richard Alexander; Richard L Eckert
Journal:  Mol Cancer Res       Date:  2019-11-15       Impact factor: 5.852

8.  Validation of multispectral singlet oxygen luminescence dosimetry (MSOLD) for photofrin-mediated photodynamic therapy.

Authors:  Ryan D Hall Morales; Hongjing Sun; Yi Hong Ong; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2022-03-04

9.  In-vivo Light dosimetry for pleural PDT.

Authors:  Andreea Dimofte; Timothy C Zhu; Jarod C Finlay; Melissa Cullighan; Christine E Edmonds; Joseph S Friedberg; Keith Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-01-24

10.  PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).

Authors:  Yi Hong Ong; Michele M Kim; Jarod C Finlay; Andreea Dimofte; Sunil Singhal; Eli Glatstein; Keith A Cengel; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2017-12-29       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.